CINECA IRIS Institutional Research Information System

ANTONIOLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.530
EU - Europa 5.307
AS - Asia 3.493
SA - Sud America 529
AF - Africa 270
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.289
IT - Italia 2.270
CN - Cina 1.348
SG - Singapore 1.102
SE - Svezia 811
BR - Brasile 482
BG - Bulgaria 445
DE - Germania 415
HK - Hong Kong 343
GB - Regno Unito 273
AT - Austria 244
RU - Federazione Russa 243
VN - Vietnam 228
TR - Turchia 227
CA - Canada 211
FI - Finlandia 167
CI - Costa d'Avorio 148
UA - Ucraina 106
IN - India 84
FR - Francia 76
NL - Olanda 56
BE - Belgio 45
SN - Senegal 44
PL - Polonia 43
CH - Svizzera 39
NG - Nigeria 33
IR - Iran 25
KR - Corea 21
JP - Giappone 20
MX - Messico 19
PK - Pakistan 19
AR - Argentina 17
CZ - Repubblica Ceca 15
IQ - Iraq 12
UZ - Uzbekistan 11
AU - Australia 10
EC - Ecuador 9
ES - Italia 9
MA - Marocco 9
PT - Portogallo 9
CL - Cile 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
BJ - Benin 7
LT - Lituania 7
AZ - Azerbaigian 6
NO - Norvegia 6
BD - Bangladesh 5
EG - Egitto 5
IE - Irlanda 5
IL - Israele 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
CO - Colombia 4
ID - Indonesia 4
JM - Giamaica 4
KG - Kirghizistan 4
PY - Paraguay 4
RO - Romania 4
TW - Taiwan 4
VE - Venezuela 4
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
GH - Ghana 3
HU - Ungheria 3
LB - Libano 3
PA - Panama 3
RS - Serbia 3
GR - Grecia 2
LV - Lettonia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
PH - Filippine 2
SA - Arabia Saudita 2
TJ - Tagikistan 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.148
Salva come PNG Salva come JPEG
Città #
Fairfield 1.262
Woodbridge 1.175
Ashburn 1.117
Ann Arbor 940
Houston 831
Chandler 782
Santa Clara 760
Seattle 497
Wilmington 478
Singapore 457
Cambridge 448
Sofia 443
Shanghai 434
Milan 395
Serra 376
Hong Kong 325
New York 271
Beijing 270
Boardman 229
Princeton 192
Ottawa 188
Vienna 171
Lawrence 168
Pisa 156
Medford 150
Abidjan 148
Izmir 131
Florence 124
Jacksonville 118
Dong Ket 116
Des Moines 109
Nanjing 93
London 85
Istanbul 83
Bremen 81
Rome 77
Dearborn 73
Chicago 60
Frankfurt am Main 60
Lucca 53
Nanchang 48
Dakar 44
Lancaster 44
Ogden 44
Los Angeles 43
Brussels 42
Redwood City 40
San Diego 40
São Paulo 40
Falls Church 39
Dallas 38
Lappeenranta 38
Council Bluffs 33
Lagos 32
The Dalles 30
Boulder 29
Hefei 29
Washington 29
Bern 28
Montignoso 27
Pune 26
Helsinki 24
Warsaw 24
Guangzhou 23
Nuremberg 23
Changsha 22
Fuzhou 22
Hebei 22
Bologna 21
Kunming 21
Marseille 21
Naples 21
Tianjin 21
Livorno 20
Munich 20
Jüchen 19
Norwalk 19
Jiaxing 16
Kent 16
Phoenix 16
Rio de Janeiro 16
Detroit 15
Düsseldorf 15
Pistoia 15
Palermo 14
Shenyang 14
Shenzhen 14
Wuhan 14
Auburn Hills 13
Hangzhou 13
Padova 13
Toronto 13
Turin 13
Brno 11
Belo Horizonte 10
Nürnberg 10
Parma 10
Turku 10
Zhengzhou 10
Curitiba 9
Totale 15.332
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 434
Preparation of isoindoline derivatives for use as AMPK activators 225
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 221
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 207
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 201
Derivati benzofuranici come attivatori di AMPK 199
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 197
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 192
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 188
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 175
CD39 and CD73 in immunity and inflammation 174
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 172
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 168
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 167
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 164
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 161
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 160
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 159
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 159
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 158
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 157
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 156
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 153
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 152
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 151
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 151
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 149
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 148
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 145
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 145
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 144
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 144
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 144
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 144
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 144
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 142
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 142
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 140
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 140
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 140
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 140
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 139
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 139
Allopurinol adherence among patients with gout: an Italian general practice database study 139
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 139
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 138
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 137
Transient acute liver failure complicating transurethral resection syndrome 137
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 136
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 136
Adenosine and inflammation: what's new on the horizon? 136
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 135
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 135
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 134
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 134
Anti-CD73 in cancer immunotherapy: awakening new opportunities 133
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 133
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 133
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 132
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 132
Role of A2a adenosine in the regulation of colonic motility in normal human colon 131
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 131
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 130
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 130
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 129
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 128
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 128
Adenosine pathway and cancer: where do we go from here? 127
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 127
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 126
Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing 126
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 126
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 125
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 124
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 124
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 123
Preparation of benzofuran derivatives for use as AMPK activators 122
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 122
Adenosine regulation of the immune system 121
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 120
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 120
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 119
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 119
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 119
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 119
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 119
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 119
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 118
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 118
Risankizumab for the treatment of moderate to severe psoriasis 116
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 116
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 115
null 114
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 114
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 114
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 114
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 114
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 113
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 112
Donepezil improves vascular function in a mouse model of Alzheimer's disease 112
Totale 14.373
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020359 0 0 0 0 0 0 0 0 0 0 286 73
2020/20211.713 142 118 118 90 123 81 66 127 229 201 106 312
2021/20222.056 37 87 66 105 390 307 74 115 127 86 138 524
2022/20232.925 334 398 220 282 285 387 37 229 479 49 190 35
2023/20242.469 221 223 285 193 360 427 63 115 106 96 132 248
2024/20254.958 82 252 109 397 552 730 649 299 735 864 289 0
Totale 21.913